CTOs on the Move

St. John`s Episcopal Hospital

www.ehs.org

 
Episcopal Health Services (EHS) traces its roots almost 150 years back to the Church Charity Foundation which was founded on February 6, 1851 for aged indigent persons and for the welfare of orphans, half orphans, and other destitute children.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.ehs.org
  • 327 Beach 19th Street
    Far Rockaway, NY USA 11691
  • Phone: 718.869.7000

Executives

Name Title Contact Details

Similar Companies

InSync Healthcare Solutions

InSync Healthcare Solutions is a leading provider of integrated EMR and practice management software, revenue cycle management services and medical transcription to thousands of healthcare professionals throughout the United States. The company has leveraged advanced technology and proven business processes to provide services and solutions that translate into better efficiency for healthcare organizations. Currently, the company supports a wide range of leading hospitals, medical clinics and physician practices, including some of the most prestigious healthcare facilities in the nation.

Biotechnical Services

BSI was founded by Judith C. McDowall in 1985 to prepare documentation for FDA regulatory submissions. BSI began preparing peer reviewed technical reports for the National Toxicology Program in 1989. We obtained and have retained this prestigious

Mobilewheelchairs

Mobilewheelchairs is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kite Pharma

Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.

SH3

SH3 is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.